CRSP Overview

Company Profile

Related stocks

IDIA.SW • Switzerland

IDORSIA N

4.2 CHF

1.36B USD 1Y -8.7%

BANB.SW • Switzerland

BACHEM N

80.05 CHF

7.23B USD 1Y +37.7%

ASND • Denmark

Ascendis Pharma A/S

229.23 USD

15.08B USD 1Y +6%

MLTX • Switzerland

MoonLake Immunotherapeutics

10.82 USD

920.85M USD 1Y +16.3%

BAVA.CO • Denmark

Bavarian Nordic A/S

236.8 DKK

2.67B USD 1Y -0.7%

GHRS • Ireland

GH Research PLC

21.11 USD

1.45B USD 1Y +55.3%

ONT.L • United Kingdom

OXFORD NANOPORE TECHNOLOGIES PL

213.4 GBp

2.76B USD 1Y +34.5%

ALK-B.CO • Denmark

ALK-Abelló B A/S

227.4 DKK

7.55B USD 1Y +5.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

60.9% p.a.

Max Drawdown (5Y)

-69.5%

Sharpe Ratio (5Y)

-0.25

Beta Factor

1.76

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

High market risk: Beta of 1.76 indicates above-average volatility compared to the broader market.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (60.9% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -85.1% in the extended horizon.